Literature DB >> 18583898

Newly developed multiple myeloma in a patient with primary T-cell lymphoma of bone.

Jun-Eul Hwang1, Sang-Hee Cho, Ok-Ki Kim, Hyun-Jeong Shim, Se-Ryeon Lee, Jae-Sook Ahn, Duk-Hwan Yang, Yeo-Kyeoung Kim, Je-Jung Lee, Hyeoung-Joon Kim, Ik-Joo Chung.   

Abstract

Primary non-Hodgkin's lymphoma of bone (PLB) is rare, and generally presents as a single extensive and destructive bone lesion. Histopathologically, most cases present as diffuse large B-cell lymphoma, and T-cell lymphoma is rare. By contrast, multiple myeloma is a disease defined as the neoplastic proliferation of a single clone of plasma cells producing a monoclonal immunoglobulin. We report a case of multiple myeloma that developed during treatment of PLB in a type of T-cell. A 48-yr-old man was diagnosed as T-cell PLB, stage IE, 18 months ago. The patient received the chemoradiotherapy and salvage chemotherapy for PLB. However, the lymphoma progressed with generalized bone pain, and laboratory findings showed bicytopenia and acute renal failure. On bone marrow biopsy, the patient was diagnosed as having multiple myeloma newly developed with primary T-cell lymphoma of bone. In spite of chemotherapy, the patient died of renal failure.

Entities:  

Mesh:

Year:  2008        PMID: 18583898      PMCID: PMC2526528          DOI: 10.3346/jkms.2008.23.3.544

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  21 in total

1.  Effect of adult T-cell leukemia cells on pokeweed mitogen-induced normal B-cell differentiation.

Authors:  T Uchiyama; K Sagawa; K Takatsuki; H Uchino
Journal:  Clin Immunol Immunopathol       Date:  1978-05

2.  Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells.

Authors:  S Broder; D Poplack; J Whang-Peng; M Durm; C Goldman; L Muul; T A Waldmann
Journal:  N Engl J Med       Date:  1978-01-12       Impact factor: 91.245

3.  Plasma cell myeloma in a patient with a cutaneous T-cell lymphoma.

Authors:  E Bryant; S G Ronan; I A Iossifides
Journal:  Cancer       Date:  1982-11-15       Impact factor: 6.860

4.  Malignant lymphoma of bone.

Authors:  Hans Roland Dürr; Peter Ernst Müller; Erhard Hiller; Markus Maier; Andrea Baur; Volkmar Jansson; Hans Jürgen Refior
Journal:  Arch Orthop Trauma Surg       Date:  2002-02       Impact factor: 3.067

5.  Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group.

Authors:  R Lahtinen; M Laakso; I Palva; P Virkkunen; I Elomaa
Journal:  Lancet       Date:  1992-10-31       Impact factor: 79.321

6.  The management of primary lymphoma of bone.

Authors:  N P Mendenhall; J J Jones; B S Kramer; T M Hudson; R L Carter; W F Enneking; R B Marcus; R R Million
Journal:  Radiother Oncol       Date:  1987-06       Impact factor: 6.280

7.  A predictive model for aggressive non-Hodgkin's lymphoma.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

8.  Lymphomas of the bone: a pathological and clinical study of 54 cases.

Authors:  Umberto Gianelli; Carlo Patriarca; Alessia Moro; Maurilio Ponzoni; Roberto Giardini; Maura Massimino; Rosa Maria Alfano; Elisabetta Armiraglio; Paolo Nuciforo; Silvano Bosari; Guido Coggi; Antonina Parafioriti
Journal:  Int J Surg Pathol       Date:  2002-10       Impact factor: 1.271

9.  Malignant lymphoma of bone.

Authors:  M L Ostrowski; K K Unni; P M Banks; T C Shives; R G Evans; M J O'Connell; W F Taylor
Journal:  Cancer       Date:  1986-12-15       Impact factor: 6.860

10.  Primary bone lymphoma: experience with 52 patients.

Authors:  Pier Luigi Zinzani; Giovanna Carrillo; Stefano Ascani; Enza Barbieri; Monica Tani; Marco Paulli; Vitttorio Stefoni; Elena Sabattini; Lapo Alinari; Roberto Binazzi; Sante Tura; Michele Baccarani; Stefano A Pileri
Journal:  Haematologica       Date:  2003-03       Impact factor: 9.941

View more
  3 in total

1.  Synchronous T-Non Hodgkins Lymphoma and Multiple Myeloma: A Rare Association.

Authors:  Abhimanyu Sharma; Namrata Kaul; Neha Singh; Anurag Mehta; Gurudutt Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2019-07-17       Impact factor: 0.900

2.  Osteosarcoma: improvement in survival limited to high-grade patients only.

Authors:  Muhammad Umar Jawad; Michael C Cheung; Jennifer Clarke; Leonidas G Koniaris; Sean P Scully
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-01       Impact factor: 4.553

3.  Primary non-Hodgkin lymphoma of the right femur and subsequent metastasis to the left femur: A case report and literature review.

Authors:  Jing-Yu Hu; Dan Yu; Yao-Hui Wu
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.